HIV medication therapy management services in community pharmacies

Journal of the American Pharmacists Association

Volumn 52, Issue 6, 2012, Pages

  Kauffman, Yardlee ^a   Nair, Vidya ^b   Herist, Keith ^c   Thomas, Vasavi ^d   Weidle, Paul J ^d  

^a KAISER PERMANENTE   (United States)

^b U of WA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral therapy; Community pharmacy; HIV; Medication therapy management

Indexed keywords

VIRUS RNA;

ADVERSE OUTCOME; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CLINICAL PHARMACY; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIV EDUCATION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MONITORING; NOTE; OUTPATIENT CARE; PHARMACIST; PUBLIC-PRIVATE PARTNERSHIP; REIMBURSEMENT; VIRUS LOAD;

EID: 84885184954     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.12063     Document Type: Note

References (38)

1. Paella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era changing causes of death and disease in the HIV Outpatient Study. J Acquir Immune Defic Syndr. 2006;43:27-34.
2. Deeks S. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17:118-23.
3. Committee on HIV Screening and Access to Care, Institute of Medicine. HIV screening and access to care: health care system capacity for increased HIV testing and provision of care. Accessed at www.nap.edu/catalog/13074.html, April 14, 2011.
4. Carmichael JK, Deckard DR, Feinberg J, et al., and the AAHIVM and HIVMA Medical Workforce Working Group. 2009. Averting a crisis in HIV care: a joint statement of the American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA) on the HIV medical workforce. Accessed at www.hivma.org/WorkArea/showcontent.aspx?id=14752&LangType=1033, March 31, 2011.
5. National HIV/AIDS Strategy for the United States, Accessed at www.whitehouse.gov/administration/eop/onap/nhas/, March 31, 2011.
6. Fuller CM, Galea S, Caceres W, et al. Multi-level community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007;97:117-24.
7. Amesty S, Rivera A, Blaney S, Fuller C. Predictors of discussing HIV testing with customers among pharmacy staff registered in the New York state expanded syringe access program: preliminary findings from the Pharmacies as Resources Making Links to HIV Testing (PHARM-HIV) Study. National Harbor, MD: National HIV Summit on HIV Diagnosis, Prevention, and Access to Care; 2010.
8. Calderon Y, Cowan E, Molano F, et al. Assessing HIV testing in community pharmacies as a complementary community site to an HIV testing and counseling program based in a New York City emergency department. Boston: Conference on Retroviruses and Opportunistic Infections; 2011.
9. Amesty S, Weidle PJ, Willis L, et al. Support for in-pharmacy HIV testing and prevention services among pharmacists registered in the New York state expanded syringe access program: findings from the PHARM-HIV study. New Orleans: American Pharmacists Association Annual Meeting & Exposition; March, 2012.
10. SK&A. Consumer access to pharmacies in the United States, 2007. Accessed at www.docstoc.com/docs/22294275/Comsumer-Access-to-Pharmacies-In-the- United-States-2007.
11. Fera T, Bluml BM, Ellis WM, Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49:e52-e60.
12. Cranor CW, Bunting BA, Christenson DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
13. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203-11.
14. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc. 2004;44:337-49.
15. Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clin Infect Dis. 2011;52(suppl 2):s238-46.
16. Sutton M, Anthony MN, Vila C, et al. HIV testing and HIV treatment services in rural counties in ten southern states: service provider perspectives. J Rural Health. 2010;26:240-7.
17. Ma A, Chen D, Chau FM, et al. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010;22:1189-94.
18. Horberg MA, Hurley LB, Silverberg MJ, et al. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Acquire Immune Defic Syndr. 2007;44:531-9.
19. Horberg MA, Hurley LB, Towner WJ, et al. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2012;60:183-90.
20. Ramsell Pharmacy Solutions. Ramsell HIV Care Continuum program. Accessed at www.ramsellps.com/solutions/clinical-services.aspx, April 5, 2011.
21. Hirsch JD, Rosenquist A, Best BM, et al. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009;15:32-41.
22. Hirsch JD, Gonzales M, Rosenquist A, et al. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011;17:213-23.
23. Rosenquist A, Best BM, Miller TA, et al. Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract. 2010;16:1142-6.
24. Murphy P, Cocohoba J, Tang A, et al. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care St. 2012;26(9), 1-6.
25. Cocohoba JM, Murphy P, Peitrandoni G, et al. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc. 2012;52:e67-e73.
26. Gallant JE, Adimora AA, Carmichael JK, et al. Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition. Clin Infect Dis. 2011;53:1-7.
27. McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47:620-8.
28. Mugavero MJ, Lin HY, Willig JH, et al. Missed visit and mortality among patients establishing initial outpatient HIV treatment. J Acquir Immune Defic Syndr. 2009;48:248-56.
29. Smith SR, Golin CE, Reif S. Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications. Am J Health Syst Pharm. 2004;61:1120-9.
30. University at Buffalo School of Pharmacy and Pharmaceutical Sciences HIV Online Educational Offerings. Accessed at https://tdm.pharm.buffalo.edu/hiv- cert-main/, April 5, 2011.
31. The AIDS Education and Training Centers National Resource Center. Accessed at www.aidsetc.org/, Dec. 5, 2011.
32. American Academy of HIV Medicine. Accessed at http://aahivm.org/, March 1, 2012.
33. Beatty SJ, McCormick JM, Beale DJ, et al. Current trends in outpatient pharmacy services and billing. J Am Pharm Assoc. 2012;52:154-60.
34. Kibicho J, Owczarzak J. Pharmacists' strategies for promoting medication adherence among patients with HIV. J Am Pharm Assoc. 2011;51:746-55.
35. Scott MA, Hitch WJ, Wilson CG, Lugo AM. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement. J Am Pharm Assoc. 2012;52:175-80.
36. Kibicho J, Owczarak J. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework. AIDS Patient Care STDS. 2012;26:20-8.
37. American College of Clinical Pharmacy. Integration of pharmacists' clinical services in the patient-centered primary care medical home. Accessed at www.accp.com/docs/positions/ miscIntegrationPharmacistClinicalServicesPCMHModel3-09.pdf, Dec, 13, 2011.
38. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS ONE. 2011;6:e17502